Condition: Heart Failure With Reduced Ejection Fraction · Sponsor: Cardiac Success
Prospective, multi-center, open-label clinical study of the feasibility and initial safety and performance of the Vsling™ in patients with heart failure (HF) with evidence of reduced left ventricular ejection fraction, associated with ventricular dilation.
This description comes directly from the study's public registry record.
Tami Abudi, +972 · +972 (52) 5989833 · tami.a@cardiacsuccess.com
Always discuss trial participation with your own doctor first.
| Shamir Medical Center | Be’er Ya‘aqov, Israel | Not Yet Recruiting |
| Rambam Medical Center | Haifa, Israel | Recruiting |
| Hadassah Medical Center | Jerusalem, Israel | Not Yet Recruiting |
| Rabin Medical Center | Petah Tikva, Israel | Not Yet Recruiting |
| Tzafon Medical Center | Poria – Neve Oved, Israel | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06851949